-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
LAVA Therapeutics NV quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2024 to Q2 2025.
- LAVA Therapeutics NV Nonoperating Income (Expense) for the quarter ending June 30, 2025 was -$1.28M, a 208% decline year-over-year.
- LAVA Therapeutics NV annual Nonoperating Income (Expense) for 2024 was $5.21M, a 193% increase from 2023.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)